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Hyperoxaluria causes crystal deposition in the kidney, which leads to oxidative stress and
to injury and damage of the renal epithelium. Sodium thiosulfate (STS, Na2S2O3) is an anti-
oxidant, which has been used in human medicine for decades. The effect of STS on hyper-
oxaluria-induced renal damage is not known.
Methods
Hyperoxaluria and renal injury were induced in healthy male Wistar rats by chronic exposure
to ethylene glycol (EG, 0.75%) in the drinking water for 4 weeks. The treatment effects of
STS, NaCl or Na2SO4 were compared. Furthermore, the effects of STS on oxalate-induced
oxidative stress were investigated in vitro in renal LLC-PK1 cells.
Results
Chronic EG exposure led to hyperoxaluria, oxidative stress, calcium oxalate crystalluria and
crystal deposition in the kidneys. Whereas all tested compounds significantly reduced crys-
tal load, only STS-treatment maintained tissue superoxide dismutase activity and urine 8-
isoprostaglandin levels in vivo and preserved renal function. In in vitro studies, STS showed
the ability to scavenge oxalate-induced ROS accumulation dose dependently, reduced cell-
released hydrogen peroxide and preserved superoxide dismutase activity. As a mechanism
explaining this finding, STS was able to directly inactivate hydrogen peroxide in cell-
free experiments.
Conclusions
STS is an antioxidant, which preserves renal function in a chronic EG rat model. Its thera-
peutic use in oxidative-stress induced renal-failure should be considered.
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Introduction
Oxalate is a metabolic end product, which is excreted with the urine. In case of excessive nutri-
tional intake or pathological overproduction (e.g. due to primary hyperoxaluria, enteric hyper-
oxaluria, EG toxicity or excessive vitamin C ingestion), calcium oxalate crystals precipitate
throughout the body. The kidneys are most vulnerable to these crystals, which lead to nephro-
lithiasis, nephrocalcinosis and renal failure [1]. High oxalate concentrations cause oxidative
stress, antioxidant depletion and injury to the renal epithelium [2, 3]. Oxidants in hyperoxa-
luria appear to be mainly mitochondria-derived [4] and therefore impair the intracellular anti-
oxidant defense systems including the activity of enzymes like superoxide dismutase (SOD)
and catalase (CAT) [3, 5].
Sodium thiosulfate (Na2S2O3, STS) is a sulfur salt, which has been used since decades in
human medicine for the treatment of cyanide intoxications. Furthermore, various clinical case
reports indicate that STS exhibits calcification-preventing properties [6, 7] and reduces calci-
um phosphate mineralization in humans suffering from calciphylaxis [8], in adenine-treated
uremic rats [9] and in genetically hypercalciuric rats [10]. These anticalcifying properties of
STS are potentially related to its antioxidant effects [11]. Despite this ability to prevent calcifi-
cation, LaGrange and colleagues [12] reported that STS had no significant effect on crystal-
luria and calcium oxalate precipitation in a rat model of acute EG and NH4Cl-induced
calcium oxalate nephropathy. The reason for not observing a beneficial effect of STS in this
model has not been elucidated but may have been due to the acute, severe and irreversible kid-
ney-damaging nature of this model.
We, therefore, hypothesized that STS might have beneficial effects in a chronic and modest
model of oxalate-induced oxidative stress and kidney damage [3, 13].
To test this hypothesis, we exposed male Wistar rats to 0.75% EG in the drinking water for
28 days. During these 4 weeks, the rats received intraperitoneal (i.p.) injections of either STS,
NaCl (SC) or Na2SO4 (SS). Furthermore, the effect of STS on oxidative stress was investigated
using an in vitro system of proximal tubular LLC-PK1 cells.
Material and Methods
Animal study
The animals were purchased from Charles River, Germany and the experiments were per-
formed with all permissions required by the Swiss authorities (Sekretariat Tierversuche Her-
rengasse 1, 3011, Bern, Switzerland, Permission number BE87/11). Male Wistar rats (n = 40)
weighing between 100 and 150 g were randomly divided into five groups of eight animals
each. Group I (Control) received normal rat chow and drinking water and no additional treat-
ment. Groups II through V received ethylene glycol (EG, Fluka) at a dose of 0.75% (v/v) with
the drinking water. Group III (EG + STS) was in addition treated with sodium thiosulfate (Dr.
Franz Köhler Chemie GmbH, Bensheim, Germany), at a dosage of 0.4 g/kg body weight thrice
a week. Group IV (EG + SC) and Group V (EG + SS) received i.p. injections of sodium chlo-
ride and sodium sulfate respectively at doses of 0.4 g/kg body weight thrice a week. All treat-
ments were continued for 28 days. 24-hour urine was collected in metabolic cages at week 0, 2
and 4. On the day of sacrifice, blood was drawn and both kidneys were removed and fixed in
buffered formaldehyde. Some of the tissue was frozen in liquid nitrogen and stored at -80°C
until further use. The animals were killed by an overdose intraperitoneal injection of
sodium pentobarbitals.
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Urine and serum biochemistry
Calcium and creatinine in urine and serum were measured using calcium and creatinine assay
kits (QuantiChrome, DICA-500 and DICT-500). Urinary oxalate was measured by HPLC in
the clinical chemistry facility at University Hospital Bern. The OxiSelect 8-iso-Prostaglandin
F2a ELISA Kit (Cell Biolabs, INC., STA 337) was used to measure 8-IP in the urine.
Processing of Kidney Tissue
For observing crystals and other tissue histological changes, the sections were stained with he-
matoxylin and eosin. Crystals were counted using light microscopy. For this purpose, using the
10x magnification, 12 fields were randomly selected which typically covered almost the whole
area of a kidney cross section. For α-SMA immunostaining, sections were stained with primary
antibodies for macrophages (mouse anti-§CD68 ED1, MCA341R AbD, 1:750, Serotec Ltd, Ox-
ford, UK) and α-Smooth Muscle Actin (mouse anti- α SMA, clone 1A4 A2547, 1:10.000,
Sigma, Zwijndrecht, the Netherlands). Kidney sections were scanned using an Aperio Scan-
scope GS (Aperio Technologies, Vista, CA, USA). The extent of pre-fibrotic changes (α-SMA,
excluding vessels) was quantified using computer-assisted analysis with Aperio Imagescope
(Version 9.1, Aperio, Vista, CA, USA). For α-SMA and ED1 the ratio between the relative cor-
tical staining and the total cortical surface area was used. All computerized measurements were
performed in a blinded manner [14]. For osteopontin (OPN) immunostaining, the sections
were stained with primary antibodies for osteopontin (mouse anti-OPN, clone MPIIIB10,
1:300, Developmental Hybridoma Studies Institute, Iowa City, IA, USA), The deparaffinized
sections were washed with phosphate buffered saline (PBS, pH 7.4) and overnight antigen re-
trieval process was performed in 0.1 M Tris/HCl buffer, pH 9.0, at 80°C. The sections were
again washed with PBS, blocked with endogenous peroxidase by treating with 0.3% H2O2 in
PBS for 30 minutes and incubated with primary antibodies for 60 minutes at room tempera-
ture. Binding was detected using sequential incubation with primary antibodies associated per-
oxidase-labeled secondary and tertiary antibodies (Dakopatts, Glostrup, Denmark) for 30
minutes. All antibodies were diluted with PBS containing 1% Bovine Serum Albumin (BSA)
and 1% normal rat serum was added to the secondary and tertiary antibody dilutions. Peroxi-
dase activity was developed using 3,3’-diaminobenzidine tetrachloride (DAB) for 10 minutes
containing 0.03% H2O2. Counterstaining was performed using Mayer’s hematoxylin. Appro-
priate isotype and PBS controls were consistently negative.
To measure the activities of the enzymes superoxide dismutase (SOD) and catalase (CAT)
[15], renal tissue was immediately put into PBS-containing 0.5 mg/ml butylated hydroxytolu-
ene (BHT) to avoid oxidation and was then homogenized on dry ice. The activity of SOD and
CAT were measured using kits from Sigma (cat.no. 19160) for SOD, and from BioVision (cat.
no. K-773) for CAT, respectively.
Cell culture
The porcine proximal tubular kidney cell line LLC-PK1 was obtained from the American
Type Culture Collection (CL-101). Cells were maintained in 75 cm2 Falcon T-flasks in
DMEM (pH 7.4) containing 10% fetal bovine serum, minimal essential medium (1%), sodi-
um pyruvate (1 mM), streptomycin (0.1 mg/ml) and penicillin (100 IU/ml) at 37°C and 5%
CO2. For experiments, confluent monolayers were used, and all experiments were carried out
in PBS or in serum- and pyruvate-free DMEMmedia. To avoid confounding, potential inter-
actions of STS with the kits and chemicals used were carefully ruled out.
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STS uptake into LLC-PK1 cells
For this experiment, the LLC-PK1 cells were kept in 100 μM STS for different time periods and
the concentration of STS in the supernatant was measured by HPLC [16].
STS toxicity studies
Confluent LLC-PK1 cells, cultured in 48 well plates for 24 hrs were used for toxicity studies.
STS (20 mM) was added to these cells for 6 and 24 hrs in serum free media. After the treatment,
cells were fixed (4% formaldehyde for 1 hr) and a protein staining dye-sulforhodamine
(0.057% sulforhodamine in 1% acetic acid) was used to determine their viability, by exposing it
to cells for 30 min. Before measuring the absorbance at 570 nm, cells were washed with 1% ace-
tic acid (4 times), air dried, dissolved in 10 mM TRIS base (pH 10.5) and were put on a shaker
for 5 min for complete dissolution of dye. The percentage change in absorbance with respect to
control was calculated for all samples.
Impact of STS on Reactive Oxygen Species (ROS)
To measure SOD activity, LLC-PK1 cells were cultured in 6-well plates (1x106 cells per well in
1ml DMEM) for 24 hrs. The 70% confluent wells were washed with PBS gently and pre-treated
with STS, SC or SS (1 mM each) for 12 hrs. Oxalate (2 mM) was dissolved in serum-, phenol
red- and pyruvate-free media, mixed with STS, SC or SS (1 mM) and subsequently added to
the cells for 24 hrs. Phenol red-free media was used to avoid interferences with the colorimetric
SOD assay kit (Sigma, 19160).
ROS were measured using 5-(and-6)-carboxy-2’,7’-difluorodihydrofluorescein diacetate
(Carboxy-H2DFFDA). LLC-PK1 cells were cultured for 24 hrs in 96-well plates (10
3 cells/ml,
200 μl DMEMmedia). Then, the cells were pre-treated with STS (1 mM), SC (1 mM) or SS
(1 mM) for 12 hrs. Following this pre-treatment, oxalate (1 mM), STS (or SC or SS) and Car-
boxy-H2DFFDA dye (10 μM) were added simultaneously to the cells in PBS. After keeping
the plate in the dark for different time intervals, fluorescence was measured using a Fluoros-
can spectrophotometer at an excitation wavelength of 485 nm and an emission wavelength of
538 nm in one-hour intervals. Eight replicates were used for each condition.
As an alternative approach, hydrogen peroxide content was determined following oxalate
exposure in the presence and absence of treatments. LLC-PK1 cells were cultured in 24-well
plates (5x104 cells per well in 500μl DMEM) for 24 hrs followed by pre-treatment with STS, SC
or SS (1 mM each) for 12 hrs. Oxalate (1 mM) was dissolved in serum-, phenol red- and pyru-
vate-free media, mixed with STS, SC or SS (1 mM) and subsequently added to the cells for 72
hrs. Phenol red-free media was used to avoid interferences with the colorimetric hydrogen per-
oxide assay. Following the treatment period, the cell supernatant was centrifuged at 9.500xg
and hydrogen peroxide was determined using a commercially available kit (Biovision, K-265).
In addition to above experiment, the direct interactions of STS, SS or SC with hydrogen per-
oxide were tested in a cell-free system. To this end, STS, SC or SS (1–7 mM each) were dis-
solved in 10 ml PBS (10 mM) containing 50 mMH2O2. After 3 hrs at room temperature, H2O2
concentration changes were measured.
Statistical analysis
Differences between animal groups were analyzed and all graphs plotted using the GraphPad
software (GraphPad Software Inc., La Jolla, CA, USA). All results, including the graphs in the
figures, are given as means ± s.d. and statistical analysis was done by Students t-test, Mann
Thiosulfate in Hyperoxaluria
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Whitney analysis and one-way analysis of variance (ANOVA) with Bonferroni’s multiple com-
parison tests as appropriate.
Results
Effects of STS in an in vivomodel of oxidative stress
Using a chronic EG-induced hyperoxaluria rat model of oxidative stress, the effects of sodium
thiosulfate (Na2S2O3, STS), sodium chloride (NaCl, SC) and sodium sulfate (Na2SO4, SS) on
renal function, renal histology and oxidative stress were studied. To this end, urine and blood
were collected at 0, 2 and 4 weeks of treatment with 0.75% EG in the drinking water and the
rats sacrificed and renal histology analyzed at 4 weeks. Throughout the experiment, all animals
behaved normally and looked healthy except for one animal from the SS group, which died
without a detectable reason. Body weight was comparable in all groups (Fig 1A).
As expected, polyuria was induced by the EG treatment. This was somewhat attenuated in
the treatment groups (Table 1). Kidney weight was significantly increased in the hyperoxaluric
rats when compared to control animals (p< 0.01, Fig 1B). STS prevented the increase of kid-
ney weight (p< 0.001), an effect that was also found as a trend in the sodium chloride (SC)
and sodium sulfate (SS) treated groups. Interestingly, serum creatinine and renal creatinine
clearance of STS-treated animals were comparable to control animals. This protection of renal
function was found in the STS-treated animals only (Fig 1C).
The histo-morphological analysis of kidney tissue from different groups revealed the presence
of extensive calcium oxalate crystal aggregates in the tubules of EG-treated rats, (Fig 2A–2E).
Quantification of these aggregates revealed that all three treatment modalities ameliorated the
crystal load in the order SC> SS> STS when compared to EG (Fig 2F). The α-SMA staining
score, an indicator of interstitial fibrosis, was very high in EG-treated animals (Fig 3A–3F) but
was reduced significantly by all three treatments. Similarly, the macrophage marker, ED-1 was
highly expressed in the EG-exposed kidneys and reduced in the treated kidneys (Fig 4A–4F).
Given that STS had a comparatively weak effect on the prevention of crystal deposition as well as
smooth muscle actin and macrophages stains, we reasoned, that the preservation of renal func-
tion found in the STS group (Fig 1C) had not been due to the prevention of calcium oxalate crys-
tal deposition in the kidneys. Although the crystal load was less with the treatments, however,
the oxalate excretion remained elevated significantly among all treatments (Table 1) compared
to animals treated with EG alone. To investigate the oxidative stress induced by EG exposure, we
determined the activity of the antioxidant enzymes SOD and CAT [14] in renal tissue and the
level of 8-IP in the urine (Fig 5). While SOD was significantly reduced (p<0.05) in EG-exposed
animals, animals treated with STS showed normal SOD activity (Fig 5A). In contrast, both con-
trol groups exhibited clearly reduced SOD activity. Upon analyzing CAT activity, no significant
changes were found in all five treatment and control groups (Fig 5B). The oxidative stress mark-
er, 8-isoprostaglandin was enhanced in the urine significantly upon EG-exposure and STS ame-
liorated this increase significantly (Fig 5C). Osteopontin (OPN), an inhibitor of calcium oxalate
crystal formation was found to be expressed in the renal tissue upon EG exposure as indicated by
the OPN staining score. No significant differences in the OPN expression were however observed
among the treatment groups (S2 Fig).
As all three beneficial effects of STS, the preservation of creatinine clearance, SOD activity
and 8-IP levels closely paralleled each other, we chose to further investigate the antioxidant
properties of STS in vitro.
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Fig 1. Treatment effects on body weight, kidney weight and renal function. (A) Initial body weight and
weight gain were similar in all animal groups irrespective of the treatment modality. (B) Kidney weight was
increased in the EG group, but near-to-normal in the EG+STS, EG+SC and EG+SS groups. (C) Creatinine
clearance derived from 24-hour urine samples collected after 4 weeks shows preserved renal function in
STS-treated animals. The significance levels are with reference to the EG group. Data are presented as
means ± SD from 7–8 animals per group *p< 0.05, **p < 0.01, ***p < 0.001.
doi:10.1371/journal.pone.0124881.g001
Thiosulfate in Hyperoxaluria
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Effects of STS in an in vitromodel of oxidative stress
To investigate the antioxidant effect of STS with kidney cells in vitro, the proximal tubular cell
line LLC-PK1 was chosen because (i) it possesses the capacity to metabolize STS (Fig 6B) and
(ii) proximal tubular cells are vulnerable to ischemia and oxidative stress [17]. Potential STS
toxicity was ruled out by exposing LLC-PK1 cells to 1 to 20 mM STS for 24 hrs and determin-
ing cell viability using sulforhodamine (Fig 6A). For the investigation of intracellular reactive
oxygen species, H2DFFDA was used. This non-fluorescent compound becomes fluorescent
Table 1. Urine and serum biochemistry.
Control EG EG+STS EG+SC EG+SS
Urine Volume, ml/d T0 7.5 ± 2.0 7.2 ± 3.0 7.2 ± 2.6 8.6 ± 1.8 9.8 ± 2.8
Volume, ml/d T2 13.2 ± 3.6 25.6 ± 11.8 21.1 ± 6.9 19.4 ± 10.0 19.1 ± 9.6
Volume, ml/d T4 17.2 ± 6.7 31.0 ± 5.9 26.4 ± 6.1 22.7 ± 9.9 23.4 ± 6.6
Oxalate (μmol/d, T4) 12.33 ± 1.64* 93.72 ± 40.24 76.53 ± 37.13 53.63 ± 17.39 58.50 ± 30.98
Calcium (mg/d, T4) 3.55 ± 1.39* 5.33 ± 0.96 4.98 ± 0.98 3.96 ± 1.42* 4.45 ± 1.06
Creatinine (mmol/d, T4) 0.048 ± 0.01* 0.037 ± 0.00 0.044 ± 0.00* 0.038 ± 0.01 0.033 ± 0.00
Serum Calcium (mg/dl, T4) 9.74 ± 1.19 9.72 ± 0.56 9.85 ± 1.25 9.00 ± 1.17 9.32 ± 1.24
Creatinine (μM, T4) 50.73 ± 8.4* 63.03± 11.0 50.84 ± 8.2* 61.50± 14.8 57.23 ± 23
CrCl (ml/min, T4) 0.67 ± 0.20* 0.44 ± 0.10 0.63 ± 0.19* 0.46 ± 0.22 0.48 ± 0.22
Data are means ± SD from 7–8 animals per group. Signiﬁcance levels are with reference to the EG group.
*p< 0.05 is statistically signiﬁcant. T0 = week 0, T2 = week 2, T4 = week 4.
doi:10.1371/journal.pone.0124881.t001
Fig 2. EG-induced changes of kidney histology.Representative hematoxylin- and eosin-stained kidney sections obtained from (A) control, (B) EG-
exposed, (C) EG+STS-exposed, (D) EG+SC-exposed, (E) EG+SS-exposed animal groups. Arrows indicate calcium oxalate crystal deposits. (F) Results of
light microscopic quantification of crystal aggregates. The data are means ± SD from 7–8 animals per group. The significance levels are with reference to the
EG group. *p< 0.05, **p < 0.01, ***p < 0.001.
doi:10.1371/journal.pone.0124881.g002
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Fig 3. α-SMA stain of kidney tissue. The groups are (A) control, (B) EG-exposed, (C) EG+STS-exposed, (D) EG+SC-exposed, (E) EG+SS-exposed
animals. The α -SMA stain was markedly increased in EG-exposed animals but decreased in all treatment groups. The significance levels are with reference
to the EG group. The data are means ± SD from 7–8 animals per group. *p< 0.05, **p < 0.01, ***p < 0.001.
doi:10.1371/journal.pone.0124881.g003
Fig 4. ED-1 stain of kidney tissue. The groups are (A) control, (B) EG-exposed, (C) EG+STS-exposed, (D) EG+SC-exposed, (E) EG+SS-exposed animal
groups. The ED-1 stain was markedly increased in EG-exposed animals but decreased in all treatment groups. The significance levels are with reference to
the EG group. The data are means ± SD from 7–8 animals per group. ***p < 0.001.
doi:10.1371/journal.pone.0124881.g004
Thiosulfate in Hyperoxaluria
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Fig 5. Oxidant-antioxidant status. The activities of the two antioxidant enzymes (A) Superoxide dismutase
(SOD), and (B) Catalase (CAT) were determined in renal tissue at time point 4 weeks in the control, EG,
EG+STS, EG+SC and EG+SS animal group. SOD activity was preserved with STS treatment; (C) Urinary
8-Isoprostaglandin levels were elevated in the EG-exposed animals and maintained in the normal range only in
STS-treated animals. The changes and significance levels are with reference to the EG group. The data are
means ± SD from 7–8 animals per group. *p< 0.05, **p < 0.01, ***p < 0.001.
doi:10.1371/journal.pone.0124881.g005
Thiosulfate in Hyperoxaluria
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upon reacting with reactive oxygen species (ROS) within cells. To avoid cell culture media-in-
duced auto-fluorescence, all experiments were carried out in PBS (S1A Fig). When LLC-PK1
cells were exposed to free oxalate (1 mM), increasing amounts of ROS were generated over 6
hrs (Fig 7A). Simultaneous exposure to STS (1 mM) dramatically reduced ROS while SC and
SS did not (Fig 7A). Fig 7B shows the dose-dependent ROS-quenching effect of STS over 3
hours. Fluorescence microscope imaging corroborated this finding (Fig 7C). Exposure of
LLC-PK1 cells to oxalate (2 mM) for 24 hrs caused a significant depletion of SOD, which was
maintained by STS (1mM) (Fig 8A). Furthermore, the exposure of LLC-PK1 cells to oxalate for
72 hrs led to the release of significant amounts of H2O2 into the supernatant (Fig 8B). This was
not the case when the cells were exposed to STS, indicating that the presence of STS had led to
a reduction of H2O2 in the supernatant (Fig 8B). The 72-hour oxalate exposure to LLC-PK1
caused a significant reduction in cell survival, which was maintained by STS dose-dependently
(Fig 8C). The direct interaction of STS with H2O2 was confirmed in a cell-free experiment
(Fig 8D). In contrast to STS, SC or SS did not affect H2O2 concentrations in this experiment.
Taken together, these results indicate that STS is an antioxidant with the capacity to directly
quench H2O2, both inside and outside of cells.
Discussion
Chronic EG exposure leads to hyperoxaluria, renal crystal deposition, oxidative stress and im-
paired kidney function [18–22]. Given the increasing use of STS in humans [23–25] and its re-
ported beneficial effects in calcifying/crystallizing conditions [11], we aimed to investigate the
effect of STS on EG-induced crystal burden and renal dysfunction.
In our study, STS significantly reduced EG-induced crystal load in the renal tissue, an effect,
which was paralleled by the reduction of the fibrosis marker α -SMA, the macrophage marker
ED-1 and urinary oxalate excretion. Indicating a non-specific mechanism, these effects were
not only observed in the STS-treated group, but also in the control animal groups treated with
SC or SS. The uniform increase of osteopontin expression encountered in all EG-groups indi-
cates that this crystal adhesive protein does not play a mechanistic role in this regard. A “wash-
out” of the crystals or a simple dilution of urine preventing crystal formation also appears
unlikely to explain this finding given the comparable urine volume of all EG-treated groups.
More likely, compatible changes of the ion activity products induced in the treatment and con-
trol groups may explain this finding [26]. Of note, a crystal reduction was not found in a more
Fig 6. STS is non-toxic and can be incorporated by the LLC-PK1 cells. (A) In vitro toxicity studies with LLC-PK1 cells showed no significant changes in
cell viability even at 20 mM STS for a period of 24 hrs in serum and pyruvate free DMEMmedia. (B) STS is decreasing in the supernatant of LLC-PK1 cells as
detected by HPLC (HepG2 used as positive control and blank wells as negative control).
doi:10.1371/journal.pone.0124881.g006
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acute and aggressive EG-model where EG along with ammonium chloride was used to induce
crystaluria [12] and potentially overruled the beneficial effects observed in our study.
Despite the comparable effects of all treatments on crystal load and tissue changes in our
study, creatinine clearance [27] was preserved in the STS-treated animal group only, an effect
potentially due to the proposed antioxidant effects of STS [11]. STS is rapidly excreted by the
kidney [16] and partially exchanged and metabolized by proximal tubular cells [28].
Oxalate and calcium oxalate crystals cause the generation of superoxide radicals [29] mainly
via PKC-regulated NADPH oxidase [30, 31] and xanthine oxidase (XO) [32] [33] pathways in
the mitochondria [34]. Free radical oxidants are short lived and their dismutation to H2O2,
which represents the major oxidant burden, occurs at a very rapid rate [35]. Concurrently, the
Fig 7. STS reduces intracellular oxidative stress.Oxidative stress was induced by exposure of proximal tubular LLC-PK1 cells towards 1 mM oxalate, and
detected using the fluorescence dye H2DFFDA. (A) Fluorescence changes in untreated LLC-PK1 cells (Control), oxalate (Ox)-exposed LLC-PK1 cells (1
mM), and Ox+STS, Ox+SC and Ox+SS-exposed LLC-PK1 cells. STS largely protects LLC-PK1 cells against oxalate-induced oxidative stress. (B) Dose-
dependent protection by STS against oxalate-induced ROS in LLC-PK1 cells. Data were analyzed by one-way analysis of variance (ANOVA) with
Bonferroni’s multiple comparison. Asterisks (*) indicate statistically significant differences (p < 0.05) with respect to oxalate-exposed cells. (C) H2DFFDA-
and DAPI-fluorescence imaging of LLC-PK1 cells. The absence of green fluorescence in oxalate-exposed, STS-treated LLC-PK1 cells indicates the
quenching of intracellular oxidative stress by STS. Control = 100% in (A) and (B). Significance levels are with reference to oxalate (Ox) group. The data are
means ± SD from 8 values per group. *p< 0.05, **p < 0.01, ***p < 0.001.
doi:10.1371/journal.pone.0124881.g007
Thiosulfate in Hyperoxaluria
PLOS ONE | DOI:10.1371/journal.pone.0124881 April 30, 2015 11 / 16
pre-existing antioxident enzymes clear H2O2, but if the oxidant burden stays elevated, H2O2
accumulates, diffuses across membranes and at high concentrations damages lipids, proteins
and DNA. Besides the generation of oxidants, the natural renal antioxidant system is impaired
by oxalate and calcium oxalate crystals. Specifically, the cytoplasmic Cu/Zn SOD is sensitive to
H2O2, which leads to a loss of the conformation of SOD and of the coordination bond between
Cu2+/Zn2+ions [36].
Accordingly, in our study oxalate exposure led to a pronounced intracellular increase in
ROS generation detectable by Carboxy-H2DFFDA fluorescent dye, and a release of H2O2 into
the supernatant of LLC-PK1 cells. STS, but not SC or SS reduced H2O2 presumably according
to the chemical reaction, 4H2O2 + S2O3
2-! 2SO42- + 2H+ + 3H2O [37], which is supported by
own experiments showing the production of H+ upon mixing of H2O2 with STS (data not
given). Here, STS directly reduced intracellular H2O2 in a dose-dependent manner and also
showed reductive capacity towards a ferricyanide reducing antioxidant assay (S1B Fig). Fur-
thermore, we found SOD activity to be decreased in EG-treated animal and to be restored by
STS, a result corroborated in in vitro experiments. Furthermore, the oxidative stress marker
urinary 8-Isoprostaglandin was elevated in the EG-exposed animals whereas it remained in the
Fig 8. Intra- and extracellular quenching of H2O2 by STS. (A) SOD activity was rescued by STS treatment upon 24 hours of oxalate-exposure to LLC-PK1
cells. (B) Oxalate-exposure of LLC-PK1 cells leads to the intracellular generation and accumulation of H2O2. While STS-treatment reduced the amount of
H2O2 released from the cells after 72 hours, SC- and SS-treatment did not. (C) 72 hours of oxalate-exposure of LLC-PK1 cells leads to a significant decrease
in cell viability (measured by sulforhodamine), which was maintained by STS in a dose dependent manner. (D) STS directly quenches H2O2 in aqueous
solution, providing evidence for a direct interaction between STS and the non-radical oxidant H2O2. SC and SS in contrast did not lead to the consumption of
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normal range in the urine of STS-treated animals. In contrast, no change in the activity of the
natural antioxidant peroxide enzyme catalase [15] was found. This is in line with previous
studies, which demonstrated a transient increase of CAT activity as an adaptive response in the
early stages of hyperoxaluria but not after 42 days of chronic EG exposure [38, 39].
The lack of an increase in CAT activity might contribute to chronically elevated H2O2 tissue
levels and explain the positive effects of H2O2-quenching compounds on the preservation of
renal dysfunction [40].
As oxalate even at physiological concentrations and in the absence of calcium oxalate crys-
tals causes significant oxidative renal cell injury [2], antioxidants like Vitamin E [13], polyphe-
nol-rich plant extracts, N-acetylcycteine [38], taurine [41] and glutathione appear to be of use
to protect against oxidative-stress-related disease conditions [15].
Interestingly, vascular media calcification has been identified as such a condition where
H2O2 leads to the initiation of the osteogenic differentiation of vascular smooth muscle cells
and thereby triggers vascular calcification [42]. STS prevents this type of vascular calcifications
in uremic rats [9], and recently endogenous urinary thiosulfate excretion was demonstrated to
be associated with a favorable cardiovascular risk profile and a survival benefit of renal trans-
plant recipients [43].
In conclusion, our study demonstrates that STS preserves renal function in a chronic model
of EG-induced hyperoxaluria. Our data indicate that this protective effect was independent of
crystal load and at least in part due to the anti-oxidative properties of STS. Therapeutic applica-
tion of STS may be of use in hyperoxaluria and other conditions characterized by the genera-
tion of the non-radical oxidant H2O2.
Supporting Information
S1 Fig. (A) Analysis of auto-fluorescence of H2DFFDA in DMEM and PBS. Fluorescence in-
creases in serum free DMEM (media) and no change in H2DFFDA fluorescence was observed
in PBS. (B) The ferric cyanide (Fe3+) reducing antioxidant power (FRAP) assay of STS.
FRAP was performed to assess reducing capability. In case of STS and positive control N-acetyl
cysteine (NAC), absorbance increased steadily with increasing concentrations whereas SS & SC
did not show any change. The results demonstrate the electron donating properties of STS for
neutralizing free radicals by forming stable products. The data are means ± SD from 8 values
per group.
(TIF)
S2 Fig. Quantification of osteopontin expression. The crystal adhesive protein, osteopontin
(OPN) was assessed in the renal tissue sections. The OPN staining significantly increased in
EG-exposed animals and remained elevated among all treatment groups indicating no impact
of these molecules on OPN expression.
(TIF)
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